Abel T, Havekes R, Saletin JM, Walker MP (2013) Sleep, plasticity and memory from molecules to whole-brain networks
Glorioso is the founder and CEO of NeuroAge Therapeutics
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
Sheu, MD, PhD, Contributor Prescriptions for the weight-loss drugs known as GLP-1s - especially semaglutide (Wegovy) and tirzepatide (Zepbound) - have surged in recent years
This review process will culminate in a final decision in August 2025
doi: 10.1016/j.metabol.2023.155533 [DOI] [PubMed] [Google Scholar] 71